Trial Profile
Multicenter, Open Label, Randomized and Parallel Group Phase IV Pilot Study Evaluating the Effectiveness of Functional Rehabilitation Protocol in RRMS Patients Treated With Betaferon.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 01 Apr 2022
Price :
$35
*
At a glance
- Drugs Interferon beta-1b (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Bayer
- 01 Apr 2022 This trial has been completed in France, according to European Clinical Trials Database record.
- 06 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Sep 2009 Status changed from completed to discontinued as reported by ClinicalTrials.gov.